Cargando…
A Bayesian non-inferiority approach using experts’ margin elicitation – application to the monitoring of safety events
BACKGROUND: When conducing Phase-III trial, regulatory agencies and investigators might want to get reliable information about rare but serious safety outcomes during the trial. Bayesian non-inferiority approaches have been developed, but commonly utilize historical placebo-controlled data to define...
Autores principales: | Aupiais, Camille, Alberti, Corinne, Schmitz, Thomas, Baud, Olivier, Ursino, Moreno, Zohar, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751616/ https://www.ncbi.nlm.nih.gov/pubmed/31533631 http://dx.doi.org/10.1186/s12874-019-0826-5 |
Ejemplares similares
-
Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE)
por: Schmitz, Thomas, et al.
Publicado: (2019) -
Bayesian treatment comparison using parametric mixture priors
computed from elicited histograms
por: Thall, Peter F, et al.
Publicado: (2017) -
Expert agreement in prior elicitation and its effects on Bayesian inference
por: Stefan, Angelika M., et al.
Publicado: (2022) -
Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations
por: Ursino, Moreno, et al.
Publicado: (2017) -
Bayesian variable selection based on clinical relevance weights in small sample studies—Application to colon cancer
por: Boulet, Sandrine, et al.
Publicado: (2019)